Oral Session 2-8A Transplant for acule leukemia

[OS2-8A-5] Allogeneic hematopoietic stem cell transplantation in patients with B-ALL with t(4;11)(q21;q23)

Jun Aoki¹, Shin Fujisawa¹, Shuichi Mizuta², Yukiyasu Ozawa³, Kazuteru Ohashi⁴, Shuichi Ota⁵, Hiroyasu Ogawa⁶, Takahiro Fukuda⁷, Naoyuki Uchida⁸, Junji Tanaka⁹, Yoshiko Atsuta¹⁰, Shinichi Kako¹¹ (1.Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan, 2.Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan, 3.Department of Hematology, Red Cross Nagoya First Hospital, Nagoya, Japan, 4.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 5.Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan, 6.Division of Hematology, Hyogo College of Medicine, Nishinomiya, Japan, 7.Department of HSCT, National Cancer Center Hospital, Tokyo, Japan, 8.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 9.Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan, 10.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 11.Division of Hematology, Saitama Medical Center, Jichi University, Omiya, Japan)